Kukje Pharma chair Nam Young Woo voting stake holds steady at 37.95% after share gift filing
Bitget2026/10/06 22:30Kukje Pharma’s controlling shareholder group raised its stake in Kukje Pharma to 8,031,092 shares, unchanged at 37.95%, as of Oct. 6, 2026. Voting rights held matched the shareholding at 8,031,092 votes, unchanged at 37.95%. The filing cited a share gift within related parties, with affiliated executives added as new related persons. Pledged shares under major contracts stayed at 3,957,991 shares, or 18.71%. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kukje Pharma Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261006000461), on October 07, 2026, and is solely responsible for the information contained therein.
- Kukje Pharma’s controlling shareholder group raised its stake in Kukje Pharma to 8,031,092 shares, unchanged at 37.95%, as of Oct. 6, 2026.
- Voting rights held matched the shareholding at 8,031,092 votes, unchanged at 37.95%.
- The filing cited a share gift within related parties, with affiliated executives added as new related persons.
- Pledged shares under major contracts stayed at 3,957,991 shares, or 18.71%.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Jensen Huang's influence surpasses that of Nvidia— and that's exactly the problem
Jensen Huang has been the key driving force behind the massive expansion of AI infrastructure, with his personal credibility and authoritative decision-making deeply embedded in the narrative of the global tech market’s rise over the past three years. Now, as scandals emerge, Nvidia’s trading team is expected to become more conservative and slow down external financing commitments, which undoubtedly worsens the situation for neoclouds already facing tight funding.
Deutsche Bank made significant Q3 purchases of midstream AI application stocks: the three major cloud giants saw increased holdings, with Palantir (PLTR.US) and Salesforce (CRM.US) also favored.
Deutsche Bank has submitted its third quarter 13F holdings report for the period ending September 30, 2026.
Crypto prices
More
